Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
  1. 4 Planned sale General Counsel sold 56,894 shares at an average $209.24 ($11,904,247)
  2. 4 Planned sale See Remarks sold 86,000 shares at an average $209.20 ($17,991,107)
  3. 4 Planned sale Director sold 5,580 shares at an average $187.99 ($1,048,967)
  4. 4 Planned sale Chief Financial Officer sold 20,000 shares at an average $168.33 ($3,366,604)
  5. 4 Grant or award Director acquired 1,191 shares (grant or award)
  6. 4 Grant or award Director acquired 1,191 shares (grant or award)
  7. 4 Grant or award Director acquired 1,191 shares (grant or award)
  8. 4 Grant or award Director acquired 1,191 shares (grant or award)
  9. 4 Grant or award Director acquired 1,191 shares (grant or award)
  10. 4 Grant or award Director acquired 1,191 shares (grant or award)
  11. 4 Grant or award Director acquired 1,191 shares (grant or award)
  12. 4 Open-market sale See Remarks sold 4,615 shares at $156.12 ($720,490)
  13. 4 Planned sale See Remarks sold 10,020 shares at $156.12 ($1,564,310)
  14. 4 Planned sale General Counsel sold 2,157 shares at $156.12 ($336,749)
  15. 4 Planned sale Chief Financial Officer sold 2,722 shares at $156.12 ($424,956)
  16. 4 Planned sale See Remarks sold 4,175 shares at $156.12 ($651,798)
  17. 4 Planned sale Chief Operating Officer sold 93,575 shares at an average $160.00 ($14,972,110)
  18. 4 Planned sale Chief Operating Officer sold 10,000 shares at an average $148.01 ($1,480,139)
  19. 4 Planned sale See Remarks sold 3,121 shares at an average $153.99 ($480,611)
  20. 4 Planned sale See Remarks sold 3,120 shares at an average $132.41 ($413,129)

Page 2 of 21 · 412 filings